EMA Authorised: Tasmar (tolcapone) — Viatris Healthcare Limited

View source ↗

Summary

The European Medicines Agency authorised Tasmar (tolcapone) by Viatris Healthcare Limited for the treatment of Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Tasmar (tolcapone)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Viatris Healthcare Limited. Decision date: 08/09/2025